IRADIMED CORPORATION Announces Second Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
August 01, 2024 09:29 ET
|
iRadimed Corporation
Reports record revenue of $17.9 million for the second quarter of 2024, an increase of 11.2 percent over the comparable period 2023.Reports GAAP diluted EPS of $0.38 and non-GAAP diluted EPS of $0.42...
IRADIMED CORPORATION to Hold 2024 Second Quarter Financial Results Conference Call on August 1st
July 25, 2024 08:30 ET
|
iRadimed Corporation
Winter Springs, Fla., July 25, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 second quarter financial results before the market...
IRADIMED CORPORATION Announces Uplisting to The Nasdaq Global Market
June 07, 2024 08:30 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., June 07, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (“Iradimed”) (NASDAQ: IRMD), a leading provider of innovative magnetic resonance imaging (MRI) compatible medical...
IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
May 02, 2024 08:30 ET
|
iRadimed Corporation
Reports record revenue of $17.6 million for the first quarter of 2024.Reports GAAP diluted EPS of $0.32 and non-GAAP diluted EPS of $0.36 for the first quarter of 2024.Reports first quarter of 2024...
IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd
April 25, 2024 16:05 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 first quarter financial results before the market...
IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference
March 13, 2024 16:30 ET
|
iRadimed Corporation
IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference
IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results
February 08, 2024 08:05 ET
|
iRadimed Corporation
Reports record revenue of $17.5 million for the fourth quarter and $65.6 million for the full year of 2023. Reports GAAP diluted EPS of $0.36 and non-GAAP diluted EPS of $0.39 for the fourth quarter...
IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.
February 01, 2024 16:05 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 fourth quarter financial results before the market...
IRADIMED CORPORATION Reports Unaudited Fourth Quarter and 2023 Revenue
January 09, 2024 08:30 ET
|
iRadimed Corporation
Reports preliminary fourth quarter 2023 revenue of $17.5 million WINTER SPRINGS, Fla., Jan. 09, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), a leader in developing...
IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 02, 2024 16:30 ET
|
iRadimed Corporation
IRADIMED CORPORATION Announces Participation in 42nd Annual J.P. Morgan Healthcare Conference